Business Context and Reporting Period
This Form 6-K filing by Ambev S.A. covers the month of February 2023, with the report signed on February 7, 2023. The filing serves as a compliance report under Article 11 of CVM Instruction # 358/2002 regarding transactions with securities and derivatives.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure regarding treasury share positions and does not contain financial performance data.
Material Changes
There were no securities and derivatives operations conducted by the registrant in January 2023. Consequently, there were no material changes to the company's treasury share positions during the reporting period.
- Initial Balance (Common Shares): 8,482,160
- Transactions: None
- Final Balance (Common Shares): 8,482,160
- ADR Common: 0
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to confirming the absence of trading activity in the specified month.
Investor Verification Points
- Verify that the treasury share count of 8,482,160 common shares remains accurate in subsequent filings.
- Confirm that no derivative positions were held or traded during the period, as explicitly stated.
- Note that this filing does not replace quarterly or annual financial reports (Form 20-F) for performance analysis.